Avai Bio Stock

Avai Bio Equity

The The Equity of Avai Bio (AVAI) as of Aug 5, 2026 is -1.56 M USD. In the previous year, The Equity was -1.47 M USD — a change of 6.63% (lower).

Equity

-1.56 MUSD

YoY

6.63%

Last updated:

In 2026, Avai Bio's equity was -1.56 M USD, a 6.63% increase from the -1.47 M USD equity in the previous year.

Access this data via the Eulerpool API

Avai Bio Stock analysis

What does Avai Bio do? Trend Innovations Holding Inc is a multi-awarded developer and manufacturer of innovative products and technologies with locations in the USA and Europe. The privately held company offers its services in various sectors, including aviation, defense, medicine, energy, industrial automation, and advanced electronics. The company was founded in 2000 and has since continuously evolved. Over the years, it started as a supplier to the aerospace industry and then became active in various fields such as medicine, energy, and industrial automation. Trend Innovations has established itself as an innovative developer and manufacturer of advanced technologies and products, gaining a reputation as a trusted partner that is always up-to-date with the latest technology. The mission of Trend Innovations is to provide tailored solutions to customers worldwide based on their specific needs and requirements. The company offers a wide range of services, including engineering and design, prototyping, manufacturing and assembly, as well as consulting and support. The company places great importance on quality, reliability, and quick responsiveness. In the aviation sector, Trend Innovations is a leading provider of aviation solutions used in both civil and military aviation. The offerings include flight control and navigation systems, structure and component developments, wireless communication solutions, and aircraft cabin systems. In the defense sector, Trend Innovations offers highly specialized technologies and products designed for military use and security agencies. These include camouflage solutions, weapon systems, communication and reconnaissance systems, as well as protection systems. In the medical field, Trend Innovations develops and manufactures medical products that contribute to improving the quality of life for patients. The offerings include medical devices for diagnosis and therapy, implants and prostheses, as well as medical instruments and consumables. In the energy industry, Trend Innovations develops innovative products and solutions that help reduce energy consumption and promote the use of renewable energies. The offerings include energy management and control solutions, solar-powered devices and components, as well as energy-saving and efficiency systems. In the industrial automation sector, Trend Innovations offers solutions for automating production processes. The offerings include robotics systems, collaborative robotics, autonomous transport systems, and automation solutions for manufacturing, storage, and logistics. Trend Innovations offers a wide range of products, including flight control and navigation systems, in-flight entertainment solutions for civil and military aviation, medical devices, implants and prostheses, automated production and transport systems, as well as sustainable energy solutions. All products from Trend Innovations are tailored to the specific needs of customers and manufactured according to the highest quality standards. In conclusion, Trend Innovations Holding Inc is an innovative developer and manufacturer of technologies and products in various sectors such as aviation, defense, medicine, energy, and industrial automation. With a wide range of services and products tailored to the specific needs of customers, Trend Innovations has established itself as a reliable partner in the market. The company has an impressive history and, thanks to its expertise and innovation, remains at the forefront of technology. Avai Bio is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Avai Bio's Equity

Avai Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Avai Bio's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Avai Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Avai Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Avai Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Avai Bio stock

The Equity of Avai Bio is -1.56 M USD in 2026.

The Equity of Avai Bio changed from -1.47 M USD to -1.56 M USD, representing a 6.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Avai Bio since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Avai Bio historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Avai Bio

All Key Metrics — Avai Bio